Nano-X Imaging awards Ofir Koren 28,283-share stock grant
The RSUs vest in four semi-annual installments from February 2027 through August 2028, subject to continued employment on each vesting date.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Nano-X Imaging Ltd. General Manager, ARC Division Ofir Koren received a grant of 28,283 ordinary shares represented by RSUs on October 10, 2026, under the 2019 Equity Incentive Plan. The RSUs vest in four equal semi-annual installments beginning February 13, 2027, subject to continuous employment on each vesting date. Koren also reported direct options covering 100,000 ordinary shares at a $49.68 exercise price, 25,000 at $17.63, and 33,500 at $11.52; the first two option tranches are fully vested and exercisable.
Insider Trade Summary
Grant/Award: 28,283 shares
Grant/Award
7 txns
Insider
Koren Ofir
Role
General Manager, ARC Division
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares F1, F2 | 28,283 | $0.00 | $0.00 |
| holding | Stock Option (right to buy ordinary shares) F3, F6 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F3, F7 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F3, F8 | -- | -- | -- |
| holding | Ordinary Shares F3 | -- | -- | -- |
| holding | Ordinary Shares F3, F4 | -- | -- | -- |
| holding | Ordinary Shares F3, F5 | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 87,757 shares (Direct);
Stock Option (right to buy ordinary shares) — 158,500 contracts (Direct)
Footnotes (8)
- F1. The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 28,283 ordinary shares represented by 28,283 restricted share units ("RSUs"), pursuant to the Issuer's 2019 Equity Incentive Plan.
- F2. The 28,283 RSUs reported in this row vest and settle for underlying ordinary shares in four equal semi-annual installments of 25% each following the vesting commencement date of August 13, 2026-- on February 13, 2027, August 13, 2027, February 13, 2028 and August 13, 2028, subject, in each case, to the Reporting Person's continuous employment by the Issuer as of the applicable vesting date, such that by the two-year anniversary of the vesting commencement date (August 13, 2028) all underlying shares will be issued to the Reporting Person.
- F3. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F4. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer on April 16, 2024 and that vest and settle for underlying ordinary shares in 16 equal quarterly installments (each for 6.25% of the RSUs granted) such that by the four-year anniversary of the grant date (April 16, 2028) all underlying shares will be issued to the Reporting Person.
- F5. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer on February 5, 2026, of which 50% vest and settle for underlying ordinary shares on the 12-month anniversary of the grant date (February 5, 2027) and the remaining 50% on the 24-month anniversary of the grant date (February 5, 2028).
- F6. The options reported in this row were granted to the Reporting Person by the Issuer on January 18, 2021 and are fully vested and exercisable as of the date of this report.
- F7. The options reported in this row were granted to the Reporting Person by the Issuer on March 28, 2022 and are fully vested and exercisable as of the date of this report.
- F8. The options reported in this row were granted to the Reporting Person by the Issuer on May 23, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable by the four-year anniversary of the grant date (May 23, 2027).
Key Figures
RSU grant: 28,283 ordinary shares represented by RSUs
RSU vesting schedule: 4 installments of 25% each
Option position: 100,000 underlying ordinary shares; $49.68 exercise price
+2 more
5 metrics
RSU grant
28,283 ordinary shares represented by RSUs
Granted to Ofir Koren on October 10, 2026, under the 2019 Equity Incentive Plan
RSU vesting schedule
4 installments of 25% each
Equal semi-annual installments, subject to continuous employment at each vesting date
Option position
100,000 underlying ordinary shares; $49.68 exercise price
Direct options, fully vested and exercisable; expiration date January 18, 2031
Option position
25,000 underlying ordinary shares; $17.63 exercise price
Direct options, fully vested and exercisable; expiration date March 28, 2032
Option position
33,500 underlying ordinary shares; $11.52 exercise price
Direct options; expiration date May 23, 2033; vesting in 16 equal quarterly installments
Key Terms
restricted share units, semi-annual installments, fully vested and exercisable
3 terms
semi-annual installments financial
"vest and settle for underlying ordinary shares in four equal semi-annual installments"
fully vested and exercisable financial
"fully vested and exercisable as of the date of this report"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many RSUs did NNOX grant Ofir Koren?
Nano-X Imaging granted General Manager, ARC Division Ofir Koren 28,283 RSUs, representing ordinary shares, under its 2019 Equity Incentive Plan.
When do Ofir Koren's NNOX RSUs vest?
They vest in four equal semi-annual installments on February 13, 2027, August 13, 2027, February 13, 2028 and August 13, 2028. Each installment is subject to Koren's continuous employment with Nano-X Imaging on its vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
